Lucy Fox Q&A

Lucy Fox
Haematologist

What are you researching in lay terms?

Inherited predisposition to blood cancer and bone marrow failure.

What motivated you to come and work at Peter Mac?

State-of-the-art genomic testing capabilities, meaningful potential to do work that positively impacts patients and their families.

What drives you to achieve better outcomes for cancer patients?

We have excellent blood cancer diagnostics and therapies, but we can still do better. By improving our ability to diagnose and understand the prognosis of rare genetic conditions, this will in turn lead to better, hopefully curative therapies in future.

How will your research improve outcomes for cancer patients?

Accurate diagnosis and precision medicine is crucial to the care of people with an inherited predisposition to blood cancer and bone marrow failure. My research aims to improve diagnosis, prognostication and comprehensive care of patients. In time, we hope to offer personalised novel therapies.

What do you like most about working for Peter Mac?

Working with a truly inspirational and dedicated team in world-class facilities.

Can you please detail how your research has used and benefitted from the core facilities at Peter Mac?

Blood cancer and bone marrow failure research is very much dependent on genomic testing capabilities. Peter Mac excels at this, and further, our institution constantly strives to offer the newest and best tests both in the clinical and research setting.